CD8A and cancer: Studies in mice and humans have demonstrated that various non-specific APCs, such as cancer-associated fibroblasts (CAFs), utilize a CTSS-dependent vacuolar pathway to present synthetic long peptides (SLPs) of neoantigens to cytotoxic CD8 + T cells.